Proposed Information Collection Activity; Social Services Block Grant (SSBG) Post-Expenditure Report (OMB #0970-0234), 57863-57864 [2020-20447]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 180 / Wednesday, September 16, 2020 / Notices
this application, New Republic Partners,
Inc., through its wholly-owned
subsidiary, New Republic Capital, LLC,
both of Charlotte, North Carolina, to
engage in financial and investment
advisory activities pursuant to section
225.28(b)(6) of Regulation Y.
Board of Governors of the Federal Reserve
System, September 11, 2020.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2020–20432 Filed 9–15–20; 8:45 am]
BILLING CODE P
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)).
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than October 16, 2020.
A. Federal Reserve Bank of Dallas
(Robert L. Triplett III, Senior Vice
President) 2200 North Pearl Street,
Dallas, Texas 75201–2272:
1. Snyder Holding Company,
Andrews, Texas; to become a bank
holding company by acquiring the
voting shares of West Texas State Bank,
Snyder, Texas.
B. Federal Reserve Bank of San
Francisco (Sebastian Astrada, Director,
Applications) 101 Market Street, San
Francisco, California 94105–1579:
1. Carpenter Acquisition Corporation,
Newport Beach, California; to become a
bank holding company by acquiring the
voting shares of First Colorado Financial
Corp., and thereby indirectly acquire
First Colorado National Bank, both of
Paonia, Colorado.
C. Federal Reserve Bank of St. Louis
(David L. Hubbard, Senior Manager)
P.O. Box 442, St. Louis, Missouri
63166–2034. Comments can also be sent
electronically to
Comments.applications@stls.frb.org:
1. Rhineland Bancshares, Inc.,
Rhineland, Missouri; to acquire the
voting shares of Clifford Bancshares,
Inc., Troy, Missouri, and thereby
indirectly acquire CBC Bank, St. Peters,
Missouri.
Board of Governors of the Federal Reserve
System, September 11, 2020.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2020–20433 Filed 9–15–20; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Social Services Block Grant
(SSBG) Post-Expenditure Report (OMB
#0970–0234)
Office of Community Services,
Administration for Children and
Families, HHS.
ACTION: Request for Public Comment.
AGENCY:
The Administration for
Children and Families (ACF) is
requesting a 3-year extension of the
Social Services Block Grant (SSBG)
SUMMARY:
57863
Post-Expenditure Report (OMB #0970–
0234, expiration 1/31/2021). ACF is
proposing to reduce the burden
estimates in the previously approved
request by removing use of the form for
the Pre-Expenditure Report.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
ACF is soliciting public comment on the
specific aspects of the information
collection described above.
ADDRESSES: Copies of the proposed
collection of information can be
obtained and comments may be
forwarded by emailing infocollection@
acf.hhs.gov. Alternatively, copies can
also be obtained by writing to the
Administration for Children and
Families, Office of Planning, Research,
and Evaluation (OPRE), 330 C Street
SW, Washington, DC 20201, Attn: ACF
Reports Clearance Officer. All requests,
emailed or written, should be identified
by the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: On an annual basis,
states and territories are required to
submit a Post-Expenditure Report that
details their use of SSBG funds in each
of the 29 service categories. Grantees are
required to submit their PostExpenditure Report within 6 months of
the end of the period covered by the
report.
In the previous approval request for
the Post-Expenditure Report, OCS also
requested that states voluntarily use the
Post-Expenditure Reporting form to
create a Pre-Expenditure Report, which
provides estimates of the expenditures
and number of recipients by service
category. ACF is proposing to remove
the burden associated with the use of
the Post-Expenditure Report form for
Pre-Expenditure reporting and intends
to submit a separate request to establish
a form specific to the Pre-Expenditure
Report.
Respondents: Agencies that
administer the SSBG at the state or
territory level, including the 50 States;
District of Columbia; Puerto Rico; and
the territories of American Samoa,
Guam, the Virgin Islands, and the
Commonwealth of Northern Mariana
Islands.
jbell on DSKJLSW7X2PROD with NOTICES
ANNUAL BURDEN ESTIMATES
Instrument
Annual number
of respondents
Annual number
of responses
per respondent
56
1
Post-Expenditure Reporting Form ...........................................................
VerDate Sep<11>2014
18:20 Sep 15, 2020
Jkt 250001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
E:\FR\FM\16SEN1.SGM
Average
burden hours
per response
16SEN1
110
Total/annual
burden hours
6,160
57864
Federal Register / Vol. 85, No. 180 / Wednesday, September 16, 2020 / Notices
Estimated Total Annual Burden
Hours: 6,160.
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authority: 42 U.S.C. 1397 through 1397e.
John M. Sweet Jr.,
ACF/OPRE Certifying Officer.
[FR Doc. 2020–20447 Filed 9–15–20; 8:45 am]
BILLING CODE 4184–24–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2020–N–0026]
Issuance of Priority Review Voucher;
Rare Pediatric Disease Product
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Dated: September 10, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–20387 Filed 9–15–20; 8:45 am]
BILLING CODE 4164–01–P
Notice.
The Food and Drug
Administration (FDA) is announcing the
issuance of a priority review voucher to
the sponsor of a rare pediatric disease
product application. The Federal Food,
Drug, and Cosmetic Act (FD&C Act), as
amended by the Food and Drug
Administration Safety and Innovation
Act (FDASIA), authorizes FDA to award
priority review vouchers to sponsors of
approved rare pediatric disease product
applications that meet certain criteria.
FDA is required to publish notice of the
award of the priority review voucher.
FDA has determined that KOSELUGO
(selumetinib, AZD6244), manufactured
by AstraZeneca Pharmaceuticals, LP,
meets the criteria for a priority review
voucher.
FOR FURTHER INFORMATION CONTACT:
Althea Cuff, Center for Drug Evaluation
and Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Silver Spring, MD 20993–0002,
301–796–4061, Fax: 301–796–9856,
email: althea.cuff@fda.hhs.gov.
SUMMARY:
jbell on DSKJLSW7X2PROD with NOTICES
FDA is
announcing the issuance of a priority
review voucher to the sponsor of an
approved rare pediatric disease product
application. Under section 529 of the
FD&C Act (21 U.S.C. 360ff), which was
added by FDASIA, FDA will award
priority review vouchers to sponsors of
approved rare pediatric disease product
applications that meet certain criteria.
FDA has determined that KOSELUGO
(selumetinib, AZD6244), manufactured
by AstraZeneca Pharmaceuticals, LP,
meets the criteria for a priority review
voucher.
KOSELUGO (selumetinib, AZD6244)
is indicated for the treatment of
pediatric patients 2 years of age and
older with neurofibromatosis type 1
who have symptomatic, inoperable
plexiform neurofibromas.
For further information about the Rare
Pediatric Disease Priority Review
Voucher Program and for a link to the
full text of section 529 of the FD&C Act,
go to https://www.fda.gov/ForIndustry/
DevelopingProductsforRareDiseases
Conditions/RarePediatricDiseasePriority
VoucherProgram/default.htm. For
further information about KOSELUGO
(selumetinib, AZD6244), go to the
‘‘Drugs@FDA’’ website at https://
www.accessdata.fda.gov/scripts/cder/
daf/.
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
18:20 Sep 15, 2020
Jkt 250001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2020–D–1621]
Geriatric Information in Human
Prescription Drug and Biological
Product Labeling; Draft Guidance for
Industry; Availability
Food and Drug Administration,
Health and Human Services (HHS).
ACTION: Notice of availability.
AGENCY:
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a draft
guidance for industry entitled ‘‘Geriatric
Information in Human Prescription
Drug and Biological Product Labeling.’’
This draft guidance is intended to assist
applicants of human prescription drug
and biological products in determining
the appropriate placement and content
of geriatric information in labeling. The
goal of this draft guidance is to provide
SUMMARY:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
recommendations to help ensure that
appropriate information on the use of
prescription drugs and biological
products in geriatric patients is
consistently placed in the proper
sections and subsections within labeling
so that the information is clear and
accessible to health care practitioners
and includes content that guides the
safe and effective use in geriatric
patients. This draft guidance provides
additional examples of geriatric use
statements in labeling and examples of
when the labeling regulations authorize
FDA to permit applicants to omit or
revise specific information otherwise
required in the Geriatric Use subsection.
We are withdrawing the guidance for
industry entitled ‘‘Content and Format
for Geriatric Labeling’’ (October 2001)
and replacing it with this draft
guidance.
Submit either electronic or
written comments on the draft guidance
by November 16, 2020 to ensure that the
Agency considers your comment on this
draft guidance before it begins work on
the final version of the guidance.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
DATES:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
E:\FR\FM\16SEN1.SGM
16SEN1
]]>Agencies
[Federal Register Volume 85, Number 180 (Wednesday, September 16, 2020)]
[Notices]
[Pages 57863-57864]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20447]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Proposed Information Collection Activity; Social Services Block
Grant (SSBG) Post-Expenditure Report (OMB #0970-0234)
AGENCY: Office of Community Services, Administration for Children and
Families, HHS.
ACTION: Request for Public Comment.
-----------------------------------------------------------------------
SUMMARY: The Administration for Children and Families (ACF) is
requesting a 3-year extension of the Social Services Block Grant (SSBG)
Post-Expenditure Report (OMB #0970-0234, expiration 1/31/2021). ACF is
proposing to reduce the burden estimates in the previously approved
request by removing use of the form for the Pre-Expenditure Report.
DATES: Comments due within 60 days of publication. In compliance with
the requirements of Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995, ACF is soliciting public comment on the specific aspects
of the information collection described above.
ADDRESSES: Copies of the proposed collection of information can be
obtained and comments may be forwarded by emailing
[email protected]. Alternatively, copies can also be obtained
by writing to the Administration for Children and Families, Office of
Planning, Research, and Evaluation (OPRE), 330 C Street SW, Washington,
DC 20201, Attn: ACF Reports Clearance Officer. All requests, emailed or
written, should be identified by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: On an annual basis, states and territories are
required to submit a Post-Expenditure Report that details their use of
SSBG funds in each of the 29 service categories. Grantees are required
to submit their Post-Expenditure Report within 6 months of the end of
the period covered by the report.
In the previous approval request for the Post-Expenditure Report,
OCS also requested that states voluntarily use the Post-Expenditure
Reporting form to create a Pre-Expenditure Report, which provides
estimates of the expenditures and number of recipients by service
category. ACF is proposing to remove the burden associated with the use
of the Post-Expenditure Report form for Pre-Expenditure reporting and
intends to submit a separate request to establish a form specific to
the Pre-Expenditure Report.
Respondents: Agencies that administer the SSBG at the state or
territory level, including the 50 States; District of Columbia; Puerto
Rico; and the territories of American Samoa, Guam, the Virgin Islands,
and the Commonwealth of Northern Mariana Islands.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Annual number Average burden
Instrument Annual number of responses hours per Total/annual
of respondents per respondent response burden hours
----------------------------------------------------------------------------------------------------------------
Post-Expenditure Reporting Form............. 56 1 110 6,160
----------------------------------------------------------------------------------------------------------------
[[Page 57864]]
Estimated Total Annual Burden Hours: 6,160.
Comments: The Department specifically requests comments on (a)
whether the proposed collection of information is necessary for the
proper performance of the functions of the agency, including whether
the information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden of the collection
of information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted
within 60 days of this publication.
Authority: 42 U.S.C. 1397 through 1397e.
John M. Sweet Jr.,
ACF/OPRE Certifying Officer.
[FR Doc. 2020-20447 Filed 9-15-20; 8:45 am]
BILLING CODE 4184-24-P
